Contineum Therapeutics remote jobs and company guide

Through groundbreaking technology and a deep understanding of biological pathways, we are revolutionizing the treatment of neuroscience, inflammation, and immunology (NI&I) indications at Contineum Therapeutics. As a clinical-stage biopharmaceutical company, we are dedicated to discovering and developing novel, oral small molecule therapies that target specific clinical impairments with high unmet needs. Our mission is to alter the course of disease by modulating the pathways that drive them, offering new hope to patients who often face limited options.

Our innovative approach focuses on developing treatments with clinically validated biological targets, such as the lysophosphatidic acid 1 receptor (LPA1R) and the M1 muscarinic receptor (M1R). By leveraging our internally-discovered molecules and unique drug discovery capabilities, we are advancing a pipeline of differentiated drug candidates designed to address conditions like idiopathic pulmonary fibrosis (IPF), multiple sclerosis (MS), and depression. At Contineum, we are committed to pushing the boundaries of science to deliver meaningful impact and improve the lives of patients worldwide.